by Michael ShulmanBiotechBlitz Antigenics (AGEN) got a Russian approval for its cancer immunotherapy -- a cancer "vaccine" is the sexy, headline grabbing term. This also created a few seconds of buzz around two other immunotherapy companies, Dendreon (DNDN) and Cell Genesys (
Read More...
[Source: The Money Blogs]
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment